Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG

BRIGHT MINDS BIOSCIENCES

BRIGHT MINDS BIOSCIENCES INC.

BRIGHT MINDS BIOSCIENCES clinical programs — 1063 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
19 Vestry St, New York, NY 10013, US HQ
12 Employees
Public company Type
DRUG · NYSE Ticker
Company details
Status
Public
HQ
19 Vestry St, New York, NY 10013, US
Employees
12
Programs
1063
Drugs
444
Patents
57
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

BRIGHT MINDS BIOSCIENCES projects

1,063 ClinicalTrials.gov programs sponsored by BRIGHT MINDS BIOSCIENCES.

BRIGHT MINDS BIOSCIENCES has 1,063 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,063 programs

Clinical programs

Page 21 of 23

  1. brand name metoprolol ER

    BRIGHT MINDS BIOSCIENCES INC.

    Blood Pressure

    approved small molecule completed

    1 trial

  2. buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    3 trials

  3. bupropion SR

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco-Use Disorder

    approved small molecule completed

    1 trial

  4. combination NRT

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  5. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    approved other active

    1 trial

  6. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved other completed

    1 trial

  7. medication for opioid use disorder

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule completed

    1 trial

  8. methadone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  9. naltrexone for extended release injectable suspension

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved small molecule completed

    1 trial

  10. nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Dependence

    approved small molecule completed

    2 trials

  11. sIPV+DTaP+MMR

    BRIGHT MINDS BIOSCIENCES INC.

    Vaccine

    approved mab active

    1 trial

  12. sublingual nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  13. transdermal nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule active

    1 trial

  14. varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    2 trials

  15. zyban

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  16. 10% N2O

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    small molecule completed

    1 trial

  17. 11UCB-J PET Scan

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    other completed

    1 trial

  18. 2 mg hydromorphone

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    small molecule completed

    1 trial

  19. 30% Nitrous oxide

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    small molecule completed

    2 trials

  20. ART initiation at time of HIV diagnosis

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    small molecule completed

    1 trial

  21. Alcohol(oral) and placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Drinking

    small molecule completed

    1 trial

  22. Aprepitant 0mg

    BRIGHT MINDS BIOSCIENCES INC.

    Narcotic Abuse

    small molecule completed

    1 trial

  23. Belsomra

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule active

    1 trial

  24. Bright Changyou probiotic flavored yogurt

    BRIGHT MINDS BIOSCIENCES INC.

    Intestinal Health

    other completed

    1 trial

  25. Bright Momchilovtsi Yogurt

    BRIGHT MINDS BIOSCIENCES INC.

    Constipation

    other completed

    1 trial

  26. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis C

    small molecule completed

    1 trial

  27. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Human Immunodeficiency Virus

    small molecule completed

    1 trial

  28. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    small molecule active

    1 trial

  29. Bupropion

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    small molecule completed

    1 trial

  30. Buspirone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Use Disorders

    small molecule completed

    1 trial

  31. Caffeine

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    other completed

    1 trial

  32. Cannabis (30% THC Concentrate)

    BRIGHT MINDS BIOSCIENCES INC.

    THC

    small molecule active

    1 trial

  33. Cigarette

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    small molecule completed

    1 trial

  34. Clopidogrel

    BRIGHT MINDS BIOSCIENCES INC.

    Metabolism of Clopidogrel

    small molecule completed

    1 trial

  35. Cognitive behavioral therapy for anxiety plus benzodiazepine taper

    BRIGHT MINDS BIOSCIENCES INC.

    Anxiety Disorders

    other completed

    1 trial

  36. Depot Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Dependence

    small molecule completed

    1 trial

  37. Electroencephalography (EEG)/Magnetoencephalography (MEG)/MRI

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    other completed

    1 trial

  38. Erythromycin 4% topical gel formulation:

    BRIGHT MINDS BIOSCIENCES INC.

    Inflammation; Skin

    small molecule completed

    1 trial

  39. Escitalopram

    BRIGHT MINDS BIOSCIENCES INC.

    Depressive Disorder, Major

    small molecule completed

    1 trial

  40. Fibre mixture

    BRIGHT MINDS BIOSCIENCES INC.

    Health Status

    other completed

    1 trial

  41. Fluoxetine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    small molecule completed

    1 trial

  42. Galantamine

    BRIGHT MINDS BIOSCIENCES INC.

    Addiction

    small molecule completed

    1 trial

  43. Goal2Quit + NRT Sampling

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    other completed

    1 trial

  44. Guselkumab

    BRIGHT MINDS BIOSCIENCES INC.

    Psoriasis Vulgaris

    small molecule terminated

    1 trial

  45. HCV+PWID

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infection

    small molecule completed

    1 trial

  46. HLA-B*5801 test

    BRIGHT MINDS BIOSCIENCES INC.

    Stevens-Johnson Syndrome

    gene therapy active

    1 trial

  47. Hydroxychloroquine Sulfate 200 MG [Plaquenil]

    BRIGHT MINDS BIOSCIENCES INC.

    Coronavirus Infection

    small molecule completed

    1 trial

  48. IMIQUIMOD cream 50mg/g

    BRIGHT MINDS BIOSCIENCES INC.

    Cutaneous Lupus Erythematosus

    small molecule active

    1 trial

Frequently asked questions

How many clinical projects does BRIGHT MINDS BIOSCIENCES have?

1,063 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.